June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Investigating the role of VSX2 (CHX10) in human retinogenesis using iPS cells
Author Affiliations & Notes
  • Joe Phillips
    Waisman Center, University of Wisconsin, Madison, WI
    McPherson Eye Research Institute, University of Wisconsin, Madison, WI
  • Enio Perez
    Waisman Center, University of Wisconsin, Madison, WI
  • Kyle Wallace
    Waisman Center, University of Wisconsin, Madison, WI
  • Jessica Martin
    Waisman Center, University of Wisconsin, Madison, WI
  • Ruchira Singh
    Waisman Center, University of Wisconsin, Madison, WI
  • Elizabeth Capowski
    Waisman Center, University of Wisconsin, Madison, WI
  • Lynda Wright
    Waisman Center, University of Wisconsin, Madison, WI
  • Eric Clark
    Waisman Center, University of Wisconsin, Madison, WI
  • E. Percin
    Medical Genetics, Gazi University, Ankara, Turkey
  • David Gamm
    Waisman Center, University of Wisconsin, Madison, WI
    McPherson Eye Research Institute, University of Wisconsin, Madison, WI
  • Footnotes
    Commercial Relationships Joe Phillips, None; Enio Perez, None; Kyle Wallace, None; Jessica Martin, None; Ruchira Singh, None; Elizabeth Capowski, None; Lynda Wright, None; Eric Clark, None; E. Percin, None; David Gamm, Cellular Dynamics international (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4052. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joe Phillips, Enio Perez, Kyle Wallace, Jessica Martin, Ruchira Singh, Elizabeth Capowski, Lynda Wright, Eric Clark, E. Percin, David Gamm; Investigating the role of VSX2 (CHX10) in human retinogenesis using iPS cells. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4052.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: We sought to examine the role of VSX2 in human retinal cell differentiation using induced pluripotent stem cell (iPSC) technology.

Methods: iPSCs were created from 1) a microphthalmic patient with a homozygous mutation in the homeodomain region of VSX2 and 2) an unaffected sibling. The resulting VSX2 mutant and wildtype (WT) iPSCs were differentiated into optic vesicle-like structures (OVs) as previously described. Thereafter, isolated mutant and WT OV cultures were analyzed at multiple time points during differentiation by RNA-seq, qRT-PCR, Western blot, and ICC. Furthermore, WT VSX2 was ectopically expressed in mutant VSX2 hiPSC cultures in an effort to rescue the observed phenotype.

Results: At very early stages of retinal differentiation, prior to VSX2 expression, VSX2 mutant and WT iPSC cultures were indistinguishable. At day 20 of differentiation, OVs isolated from mutant and WT iPSCs had similar retinal gene expression profiles. However, genes involved in WNT and FGF signaling were up- and downregulated, respectively, in mutant OVs compared to WT OVs. By day 30, differences in retinal gene expression were evident and, furthermore, mutant OVs showed reductions in proliferation and growth rate compared to WT OVs. Unlike WT OVs, most mutant OVs maintained MITF expression and became pigmented with time in conjunction with the expression of characteristic RPE genes. With the exception of bipolar cells, mutant OVs did generate neuroretinal cells over time, although overall amounts were reduced and maturation was delayed for some cell types. Importantly, much of the mutant OV phenotype could be rescued by ectopic expression of WT VSX2.

Conclusions: OVs derived from VSX2 mutant hiPSCs display a phenotype in culture consistent with findings in human patients and animal models. Overall, the ability to isolate and differentiate unlimited amounts of differentiating OVs from iPSCs facilitates in depth analyses and shows promise for investigating roles of key factors during retinal development.

Keywords: 698 retinal development • 688 retina • 721 stem cells  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×